(Brussels, Belgium) - - - Kidney Disease: Improving Global Outcomes is proud to announce the release of an Android version of its popular KDIGO Clinical Guidelines for Kidney Disease app. The app, currently available for iOS devices, puts all KDIGO Guidelines within easy reach. The new Android platform broadens that reach further, bringing the KDIGO app to even more clinicians around the world. The KDIGO Clinical Guidelines for Kidney Disease app is supported by an educational grant from Relypsa, Inc. and is available free-of-charge through the Apple App Store and Google Play Store.
KDIGO Co-Chair Dr. David Wheeler of University College London, said, “This tool is readily available to physicians in countries with all levels of economic development, medical sophistication, and treatment resources. Now clinicians anywhere can easily access this critical information. Adding Android devices to the resource will bring it to many more users, which is a great development.”
The KDIGO Guideline app was unveiled at the American Society of Nephrology’s Kidney Week meeting in 2013. The KDIGO app has since been downloaded more than 13,000 times. At the 2015 ASN meeting, the new Android version will be available for the first time, thanks to support from Relypsa.
“As part of Relypsa’s ongoing commitment to patients with chronic kidney disease, we are excited to support the KDIGO Android app,” said Lance Berman, M.D., chief medical officer of Relypsa. “This app will allow more clinicians access to the KDIGO Clinical Guidelines for Kidney Disease, which are comprehensive resource that greatly enhance the care of patients with kidney disease around the world.”
KDIGO Co-Chair Dr. Bertram Kasiske of the University of Minnesota, said, “We have always published and disseminated hundreds of written pages of recommendations. Now they are in the hands and on the desks of our colleagues everywhere in the world. Providing KDIGO’s work to everyone electronically will greatly enhance our global ability to fulfill our mission of improving outcomes for patients.”
For further information, please contact KDIGO at KDIGOcommunications@kdigo.org.
# # #